Tuesday , November 21 2017
Home / Therapies / DPP-4 Therapy Center (page 9)

DPP-4 Therapy Center

James R. Thrasher, MD, Q2 Patient Type for DPP-4

Dr. Thrasher discusses the recent ADA and AACE guidelines for treating patients, and the benefits of a DPP-4 for patients. More videos with Dr. Thrasher: James R. Thrasher, MD, Introduction Education, Nutrition, Physical Activity What Do You Do to Help Your Patients with Type 2 Diabetes? Difficulties with Getting Patients …

Read More »

DPP-4 Inhibitor Survey

DPP4-Survey1

During my frequent visits to prescribers’ offices I get a chance to see their prescribing habits. When it comes to DPP-4 inhibitors, medical professionals seem to have similar opinions on how to use each of the drugs from this class. But to test this theory, we contacted 25 primary care …

Read More »

Role of DPP-4 Inhibitors in Clinical Practice

DPP-4_Figure1

The dipeptidyl peptidase-4 (DPP-4) inhibitors are a newer class of oral drugs for the treatment of type 2 diabetes. They inhibit the breakdown of glucagon-like peptide-1 (GLP-1) and increase the incretin effect in patients with type 2 diabetes. In clinical practice they are associated with significant reductions in HbA1c, no …

Read More »